These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
79 related articles for article (PubMed ID: 15700180)
1. Frontal-temporal regional differences in brain energy metabolism and mitochondrial function using Lopez FV; O'Shea A; Huo Z; DeKosky ST; Trouard TP; Alexander GE; Woods AJ; Bowers D Geroscience; 2024 Jun; 46(3):3185-3195. PubMed ID: 38225480 [TBL] [Abstract][Full Text] [Related]
2. Systematic review of Jett S; Boneu C; Zarate C; Carlton C; Kodancha V; Nerattini M; Battista M; Pahlajani S; Williams S; Dyke JP; Mosconi L Front Aging Neurosci; 2023; 15():1183228. PubMed ID: 37273652 [TBL] [Abstract][Full Text] [Related]
3. Neurodegenerative Changes in the Brains of the 5xFAD Alzheimer's Disease Model Mice Investigated by High-Field and High-Resolution Magnetic Resonance Imaging and Multi-Nuclei Magnetic Resonance Spectroscopy. Yoo CH; Kim J; Baek HM; Chang KA; Choe BY Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982146 [TBL] [Abstract][Full Text] [Related]
4. Sex and menopause impact Jett S; Dyke JP; Andy C; Schelbaum E; Jang G; Boneu Yepez C; Pahlajani S; Diaz I; Diaz Brinton R; Mosconi L Sci Rep; 2022 Dec; 12(1):22087. PubMed ID: 36543814 [TBL] [Abstract][Full Text] [Related]
5. Mitochondrial dysfunction, oxidative stress, neuroinflammation, and metabolic alterations in the progression of Alzheimer's disease: A meta-analysis of in vivo magnetic resonance spectroscopy studies. Song T; Song X; Zhu C; Patrick R; Skurla M; Santangelo I; Green M; Harper D; Ren B; Forester BP; Öngür D; Du F Ageing Res Rev; 2021 Dec; 72():101503. PubMed ID: 34751136 [TBL] [Abstract][Full Text] [Related]
6. Phosphate Brain Energy Metabolism and Cognition in Alzheimer's Disease: A Spectroscopy Study Using Whole-Brain Volume-Coil Das N; Ren J; Spence J; Chapman SB Front Neurosci; 2021; 15():641739. PubMed ID: 33889067 [TBL] [Abstract][Full Text] [Related]
7. Relationship of Parieto-Occipital Brain Energy Phosphate Metabolism and Cognition Using Das N; Ren J; Spence JS; Rackley A; Chapman SB Front Aging Neurosci; 2020; 12():222. PubMed ID: 33005142 [TBL] [Abstract][Full Text] [Related]
8. The validity and reliability of the CAMDEX-DS for assessing dementia in adults with Down syndrome in Brazil. Fonseca LM; Haddad GG; Mattar GP; Oliveira MC; Simon SS; Guilhoto LM; Busatto GF; Zaman S; Holland AJ; Hoexter MQ; Bottino CM Braz J Psychiatry; 2019; 41(3):225-233. PubMed ID: 30365671 [TBL] [Abstract][Full Text] [Related]
9. Altered brain high-energy phosphate metabolism in mild Alzheimer's disease: A 3-dimensional Rijpma A; van der Graaf M; Meulenbroek O; Olde Rikkert MGM; Heerschap A Neuroimage Clin; 2018; 18():254-261. PubMed ID: 29876246 [TBL] [Abstract][Full Text] [Related]
10. The medical food Souvenaid affects brain phospholipid metabolism in mild Alzheimer's disease: results from a randomized controlled trial. Rijpma A; van der Graaf M; Lansbergen MM; Meulenbroek O; Cetinyurek-Yavuz A; Sijben JW; Heerschap A; Olde Rikkert MGM Alzheimers Res Ther; 2017 Jul; 9(1):51. PubMed ID: 28747210 [TBL] [Abstract][Full Text] [Related]
11. Increased iPLA2 activity and levels of phosphorylated GSK3B in platelets are associated with donepezil treatment in Alzheimer's disease patients. Talib LL; Hototian SR; Joaquim HP; Forlenza OV; Gattaz WF Eur Arch Psychiatry Clin Neurosci; 2015 Dec; 265(8):701-6. PubMed ID: 25920742 [TBL] [Abstract][Full Text] [Related]
12. Platelets, a reliable source for peripheral Alzheimer's disease biomarkers? Veitinger M; Varga B; Guterres SB; Zellner M Acta Neuropathol Commun; 2014 Jun; 2():65. PubMed ID: 24934666 [TBL] [Abstract][Full Text] [Related]
13. Platelet biomarkers in Alzheimer's disease. Talib LL; Joaquim HP; Forlenza OV World J Psychiatry; 2012 Dec; 2(6):95-101. PubMed ID: 24175175 [TBL] [Abstract][Full Text] [Related]
15. Phospholipase A2 activation as a therapeutic approach for cognitive enhancement in early-stage Alzheimer disease. Schaeffer EL; Forlenza OV; Gattaz WF Psychopharmacology (Berl); 2009 Jan; 202(1-3):37-51. PubMed ID: 18853146 [TBL] [Abstract][Full Text] [Related]
16. Cholinergic and glutamatergic alterations beginning at the early stages of Alzheimer disease: participation of the phospholipase A2 enzyme. Schaeffer EL; Gattaz WF Psychopharmacology (Berl); 2008 May; 198(1):1-27. PubMed ID: 18392810 [TBL] [Abstract][Full Text] [Related]
17. MR spectroscopy in neurodegenerative disease. Martin WR Mol Imaging Biol; 2007; 9(4):196-203. PubMed ID: 17279431 [TBL] [Abstract][Full Text] [Related]
18. The role of phospholipase A2 in neuronal homeostasis and memory formation: implications for the pathogenesis of Alzheimer's disease. Forlenza OV; Schaeffer EL; Gattaz WF J Neural Transm (Vienna); 2007 Feb; 114(2):231-8. PubMed ID: 17131232 [TBL] [Abstract][Full Text] [Related]